Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival
Sign Up to like & getrecommendations! Published in 2017 at "Leukemia"
DOI: 10.1038/leu.2016.140
Abstract: Immunoparesis is an adverse prognostic marker in plasma cell proliferative disorders. Its impact in AL amyloidosis has not been explored in depth. Newly diagnosed AL amyloidosis patients (n=998) were evaluated for immunoparesis by two methods.… read more here.
Keywords: newly diagnosed; response; diagnosed amyloidosis; amyloidosis ... See more keywords